Strata Critical Medical Inc (SRTA)

NASD · Healthcare · Medical Care Facilities · USA

Strata Critical Medical Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Care Facilities industry.

Strata Critical Medical provides urgent transportation and clinical support services to the United States transplant industry. Operating through Trinity Medical Solutions and Keystone Perfusion Services, the company offers air and ground organ delivery, surgical procurement, organ preservation techniques, and perfusion staffing to transplant hospitals and organ procurement organizations.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Strata Critical Medical Inc stock.

Our verdict on SRTA

Overvalued: intrinsic value $2.72 per share, market price $5.24, margin of safety -92.9% (as of 2026-11-17).

A 0.7x revenue multiple, discounted for its losses, values the shares at $2.72; the price of $5.24 is 93% above that value.

ETFs with the most weight in SRTA

17 more funds hold it; the full list is part of the paid plan.

More on SRTA

Browse

Peers in Medical Care Facilities

All 48 Medical Care Facilities stocks

Cheaper than SRTA in Medical Care Facilities

21 more in this industry show a wider margin of safety.

Is SRTA undervalued or overvalued?

SRTA is overvalued (as of the 2026-11-17 close). A 0.7x revenue multiple, discounted for its losses, values the shares at $2.72; the price of $5.24 is 93% above that value.

What is the intrinsic value of SRTA?

$2.72 per share (as of the 2026-11-17 close), against a market price of $5.24. That is a margin of safety of -92.9%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.